The role of serum sphingolipids as potential biomarkers of non-response to direct acting antiviral therapy in chronic hepatitis C virus infection.
J Viral Hepat
; 30(2): 138-147, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36463431
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Hepatitis C
/
Hepatitis C, Chronic
Limits:
Humans
Language:
En
Year:
2023
Type:
Article